Literature DB >> 16599849

Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens.

Kathryn Thrailkill, Gael Cockrell, Pippa Simpson, Cynthia Moreau, John Fowlkes, R Clay Bunn.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16599849      PMCID： PMC2242291          DOI： 10.1515/CCLM.2006.090

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  13 in total

1.  Serum or plasma: what kind of blood sample should be used to measure circulating matrix metalloproteinases and their inhibitors?

Authors:  Klaus Jung
Journal:  J Neuroimmunol       Date:  2005-05       Impact factor: 3.478

2.  Blood sampling as critical preanalytical determinant to use circulating MMP and TIMP as surrogate markers for pathological processes.

Authors:  Klaus Jung; Arielle Meisser; Paul Bischof
Journal:  Int J Cancer       Date:  2005-10-10       Impact factor: 7.396

3.  Levels of matrix metalloproteinase-1 in patients with and without coronary artery disease and relation to complex and noncomplex coronary plaques.

Authors:  Ryuichi Kato; Yukihiko Momiyama; Reiko Ohmori; Hiroaki Taniguchi; Haruo Nakamura; Fumitaka Ohsuzu
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

4.  Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment.

Authors:  C Avolio; M Filippi; C Tortorella; M A Rocca; M Ruggieri; F Agosta; V Tomassini; C Pozzilli; S Stecchi; P Giaquinto; P Livrea; M Trojano
Journal:  Mult Scler       Date:  2005-08       Impact factor: 6.312

5.  Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I.

Authors:  Athanassios Manginas; Evgenia Bei; Antigoni Chaidaroglou; Dimtrios Degiannis; Katerina Koniavitou; Vassilis Voudris; Gregory Pavlides; Demosthenis Panagiotakos; Dennis V Cokkinos
Journal:  Clin Cardiol       Date:  2005-04       Impact factor: 2.882

6.  Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis.

Authors:  T Kanesaka; M Mori; T Hattori; T Oki; S Kuwabara
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

Review 7.  Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications.

Authors:  Stanley Zucker; Kaushik Doshi; Jian Cao
Journal:  Adv Clin Chem       Date:  2004       Impact factor: 5.394

8.  High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.

Authors:  Johanna Nikkola; Pia Vihinen; Meri-Sisko Vuoristo; Pirkko Kellokumpu-Lehtinen; Veli-Matti Kähäri; Seppo Pyrhönen
Journal:  Clin Cancer Res       Date:  2005-07-15       Impact factor: 12.531

9.  The role of matrix metalloproteinase 9 in the pathogenesis of chronic lymphocytic leukaemia.

Authors:  Aura S Kamiguti; Edwin S Lee; Kathleen J Till; Robert J Harris; Mark A Glenn; Ke Lin; Hai Juan Chen; Mirko Zuzel; John C Cawley
Journal:  Br J Haematol       Date:  2004-04       Impact factor: 6.998

10.  Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia.

Authors:  Stefano Molica; Gaetano Vitelli; Domenico Levato; Diana Giannarelli; Angelo Vacca; Antonio Cuneo; Franceso Cavazzini; Roberto Squillace; Rosanna Mirabelli; Giovanna Digiesi
Journal:  Eur J Haematol       Date:  2003-06       Impact factor: 2.997
View more
  12 in total

1.  Receptor cleavage reduces the fluid shear response in neutrophils of the spontaneously hypertensive rat.

Authors:  Angela Y Chen; Frank A DeLano; Shakti R Valdez; Jessica N Ha; Hainsworth Y Shin; Geert W Schmid-Schönbein
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

2.  Peptidomic Analysis of Rat Plasma: Proteolysis in Hemorrhagic Shock.

Authors:  Federico Aletti; Elisa Maffioli; Armando Negri; Marco H Santamaria; Frank A DeLano; Erik B Kistler; Geert W Schmid-Schönbein; Gabriella Tedeschi
Journal:  Shock       Date:  2016-05       Impact factor: 3.454

3.  Molecular Clustering Analysis of Blood Biomarkers in World Trade Center Exposed Community Members with Persistent Lower Respiratory Symptoms.

Authors:  Gabriele Grunig; Nedim Durmus; Yian Zhang; Yuting Lu; Sultan Pehlivan; Yuyan Wang; Kathleen Doo; Maria L Cotrina-Vidal; Roberta Goldring; Kenneth I Berger; Mengling Liu; Yongzhao Shao; Joan Reibman
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

4.  Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

Authors:  Kathryn M Thrailkill; Robert C Bunn; Cynthia S Moreau; Gael E Cockrell; Pippa M Simpson; Hannah N Coleman; J Paul Frindik; Stephen F Kemp; John L Fowlkes
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

5.  Injectable, Hyaluronic Acid-Based Scaffolds with Macroporous Architecture for Gene Delivery.

Authors:  Arshia Ehsanipour; Tommy Nguyen; Tasha Aboufadel; Mayilone Sathialingam; Phillip Cox; Weikun Xiao; Christopher M Walthers; Stephanie K Seidlits
Journal:  Cell Mol Bioeng       Date:  2019-09-04       Impact factor: 2.321

6.  Concentration kinetics of serum MMP-9 and TIMP-1 after blunt multiple injuries in the early posttraumatic period.

Authors:  M Brumann; T Kusmenkov; L Ney; K-G Kanz; B A Leidel; P Biberthaler; W Mutschler; V Bogner
Journal:  Mediators Inflamm       Date:  2012-03-27       Impact factor: 4.711

7.  Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.

Authors:  Wanda K O'Neal; Wayne Anderson; Patricia V Basta; Elizabeth E Carretta; Claire M Doerschuk; R Graham Barr; Eugene R Bleecker; Stephanie A Christenson; Jeffrey L Curtis; Meilan K Han; Nadia N Hansel; Richard E Kanner; Eric C Kleerup; Fernando J Martinez; Bruce E Miller; Stephen P Peters; Stephen I Rennard; Mary Beth Scholand; Ruth Tal-Singer; Prescott G Woodruff; David J Couper; Sonia M Davis
Journal:  J Transl Med       Date:  2014-01-08       Impact factor: 5.531

8.  3D-Printed Biodegradable Microswimmer for Theranostic Cargo Delivery and Release.

Authors:  Hakan Ceylan; Immihan Ceren Yasa; Oncay Yasa; Ahmet Fatih Tabak; Joshua Giltinan; Metin Sitti
Journal:  ACS Nano       Date:  2019-02-25       Impact factor: 15.881

9.  Heparinized chitosan stabilizes the bioactivity of BMP-2 and potentiates the osteogenic efficacy of demineralized bone matrix.

Authors:  Soyon Kim; Jiabing Fan; Chung-Sung Lee; Chen Chen; Ksenia Bubukina; Min Lee
Journal:  J Biol Eng       Date:  2020-03-06       Impact factor: 4.355

10.  Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women.

Authors:  Barbara J Jefferis; Peter Whincup; Paul Welsh; Goya Wannamethee; Ann Rumley; Lucy Lennon; Andy Thomson; Debbie Lawlor; Claire Carson; Shah Ebrahim; Gordon Lowe
Journal:  Atherosclerosis       Date:  2009-08-19       Impact factor: 5.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.